New eyedrop formula in sight for serious vision problems

New eyedrop formula in sight for serious vision problems

A new eyedrop has shown early success in delivering protective compounds to where they’re needed most in the eye, raising hopes for less invasive treatment of serious vision conditions.

The research led by RMIT University is focused on retinal diseases, especially age-related macular degeneration (AMD). AMD damages the retina, specifically the macula, which can cause blindness and affects hundreds of millions of people globally.

Key risk factors for AMD are age, family history, diet, high blood pressure, obesity, smoking and other lifestyle choices.

In the modern era, we have exposure to excessive high energy blue light from devices such as mobile phones, computer screens and televisions, which may also contribute to eye damage over time.

Six researchers in white RMIT lab coats stand together in a laboratory.The RMIT research team developing new eyedrop treatments: (front row, left to right) Dr Dao Nguyen, Associate Professor Tien Huynh and Dr Thilini Thrimawithana; (back row, left to right) Professor Charlotte Conn, Dr Sampa Sarkar and Christopher Olowosoke. Credit: Will Wright, RMIT University

The team investigated delivering lutein, a protective antioxidant compound found in Gac fruit, to the back of the eye to support retinal health and potentially slow or prevent damage.

In pre-clinical mice studies conducted in collaboration with the Centre for Eye Research Australia (CERA), the formula reached the retina at the back of the eye – currently only accessible through injections – and kept the active compound stable for months at room temperature.

A woman in a lab coat and safety glasses holds up a small vial containing an orange liquid in a laboratory.Dr Dao Nguyen examines a vial of lutein formulation developed for potential use in eyedrop treatments. Credit: Will Wright, RMIT University

The team’s cell culture study demonstrated that lutein delivered using their new formulation protected retinal cells from stress and damage linked to vision loss.

Dr Dao Nguyen, who co-led the research when she was at RMIT, said the formulation could pave the way for more patient-friendly therapies.

“Frequent eye injections are uncomfortable and can be distressing for patients. If the formulation works, people could use the eyedrop as a preventative measure that could reduce the risk of developing late-stage diseases and the need for injections,” said Nguyen, who is now at Deakin University’s School of Medicine.

“Our eyedrop formula is designed to treat early stages of age-related macular degeneration in a way that’s far easier to use, but it will take further research and clinical trials before it can reach people.”

The eyedrops would not replace injections, Nguyen said.

Four researchers in RMIT lab coats and blue gloves stand in a laboratory, holding small vials of orange lutein liquid and a packet of Gac fruit extract.RMIT researchers with Gac fruit extract, the source of lutein for their eyedrop formula: (left to right) Dr Dao Nguyen, Christopher Olowosoke, Dr Thilini Thrimawithana and Associate Professor Tien Huynh. Credit: Will Wright, RMIT University

Team leader Associate Professor Tien Huynh from RMIT’s School of Science said the delivery platform could be adapted to carry different compounds, not just the one tested in this study.

“This is a technology with broad potential. We’ve shown it can protect fragile ingredients and carry them safely to the back of the eye, which has long been a barrier for treatments,” Huynh said.

A woman in a white lab coat and safety glasses holds up a vial of white liquid in a laboratory.Professor Charlotte Conn with a vial of the cubosome formulation developed to deliver compounds safely to the back of the eye. Credit: Will Wright, RMIT University

Professor Charlotte Conn and Dr Sampa Sarkar, lead researchers on the innovative delivery method, said the RMIT-patented nanotechnology called cubosomes to deliver drugs was showing early promise for this and a range of other drug delivery applications.

“Our cubosome carriers act like tiny shields, keeping the compound safe and releasing it in a controlled way once it’s inside the eye,” said Conn, from RMIT’s School of Science.

Associate Professor Chi Luu, a clinician-scientist at CERA and the University of Melbourne, said the findings were encouraging.

“This kind of approach could transform how we manage age-related macular degeneration. If future trials confirm the safety and effectiveness of the delivery platform, eyedrops could one day be used for treating early stages of AMD and other serious retinal diseases,” Luu said.

A woman in a white RMIT lab coat and safety glasses sits at a laboratory bench pipetting an orange liquid into a clear plate surrounded by racks of test tubes.Dr Dao Nguyen working in a lab at RMIT University preparing the lutein eyedrop formulation for testing. Credit: Will Wright, RMIT University

The researchers note the work is still at an early stage: the results come from cell and animal studies, and the experiments did not test whether the formulation improved disease outcomes as the mice did not have AMD or any other retinal conditions.

The next step is to work with clinical and industry partners to test the formula further and move it towards human trials. Organisations that want to partner with RMIT researchers can contact research.partnerships@rmit.edu.au

The research, ‘Optimizing lutein formulations for targeted ocular drug delivery: in vitro and in vivo insights’, is published in the peer-reviewed journal ACS Applied Materials & Interfaces (DOI: 10.1021/acsami.5c14464).

Other co-authors on the study were Dr Thilini Thrimawithana and Professor Terrence Piva.

A pipette dispensing an orange liquid into a transparent test plate.Dr Dao Nguyen pipettes the lutein formulation into a test plate as part of research into eyedrop treatments for age-related macular degeneration. Credit: Will Wright, RMIT University

A recent literature review from the team, led by RMIT PhD scholar Christopher Olowosoke, highlights the promise of plant compounds, including lutein, for protecting eye health.

The research, ‘Non-invasive pharmacological advances in early retinopathy treatment: bioactive herbal compounds, polymer delivery systems, and computational bioprospecting of functional targets’, is published in the peer-reviewed journal Pharmacological Reports (DOI: 10.1007/s43440-025-00778-7).


Story: Will Wright

23 September 2025

Share

Return to RMIT News
23 September 2025

Share

  • STEM
  • Industry
  • Research
  • Nano & Microtechnology
  • Science and technology
Engage

Related News

Person working in lab

Developing a medical implant coating that combats infection and pain

Pursuing his passion at the intersection of engineering, biology and care, Vijay Sisarwal is developing a plant‑based biodegradable implant coating that helps support natural healing.

From L-R: Professor Cassandra Szoeke, Dr Julie Stevens, Pharmaceutical Society of Australia Victoria President Atinuke Abraham, Deputy Vice-Chancellor STEM College Professor Catherine Istiopoulos.

RMIT launches sex-specific pharmacy curriculum to address gender disparities in health

RMIT University has launched a landmark health education program in its undergraduate pharmacy degree, equipping students with the knowledge and skills needed to support sex-specific health differences in clinical practice.

Katherine Bennell-Pegg in panel discussion.

Australian of the Year brings stellar insights to inspire the next generation at RMIT

Katherine Bennell-Pegg, who is the first astronaut to officially represent Australia, visited RMIT for a tour and panel discussion taking students through her journey from physics student to space systems engineer and astronaut.

news-rmit-plant-sunscreen-1220px.jpg

Sound waves create mist that can act like ‘plant sunscreen’

RMIT University researchers have developed a new way to coat fragile surfaces, including living plant leaves, using high‑frequency sound waves to create a fine mist that can act like a plant sunscreen.

Show more
aboriginal flag float-starttorres strait flag float-start

Acknowledgement of Country

RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business - Artwork 'Sentient' by Hollie Johnson, Gunaikurnai and Monero Ngarigo.

More information